Biography

Dr. David Gruber is Director of Research with the Alvarez & Marsal Healthcare Industry Group (HIG) in New York, specializing in strategy, business development, consumer engagement, innovation, new ventures, technology, analytics and health benefits. Dr. Gruber is currently responsible for thought leadership and model development within HIG and is involved with various consulting projects, most recently an assessment pain management practices for a potential investor. He brings 30 years of diversified healthcare experience as a consultant, corporate executive, Wall Street analyst and physician. Before joining A&M, he spent three years as the Founder of Healthcare Convergence Associates, a consulting firm focused on the convergence of healthcare, technology and the consumer. Assignments included working with a multinational to explore tele-health opportunities; a medical device manufacturer to assess the feasibility of a proposed asthma and COPD technology; a pharmacy benefit manager to define innovative approaches to medication adherence in diabetes; a national retailer exploring health and wellness; a Canadian company interested in preventing nosocomial infections; and a major Wireless Health Institute to develop its strategic plan. He was also involved in three healthcare-related IT start-ups. Until 2008, Dr. Gruber was Vice President of Corporate Development and New Ventures with the Johnson & Johnson Consumer Group of Companies. His primary focus was in dermatology / aesthetics, consumer engagement and wireless health across the company. In 1995-2004, he worked on Wall Street as a top-ten rated medical supplies and devices analyst at Lehman Brothers, Piper Jaffray and Sanford Bernstein. He was the lead analyst for the initial public offering of Intuitive Surgical (robotics) and Given Imaging, and a merchant banking investment in Therasense. Prior to entering Wall Street, Dr. Gruber was Vice President of Planning and Business Development for the $1.6 billion healthcare group at Bristol-Myers that included Zimmer, ConvaTec, Linvatec and Xomed-Treace. While at Bristol-Myers, he represented the company on the Health Industry Manufacturing Association (HIMA) as it deliberated the merits of the Hillary Clinton healthcare reform proposals. Dr. Gruber is a magna cum laude graduate of a six-year B.S.-M.D. program, having received a bachelor’s degree from Sophie Davis School of Biomedical Education, CCNY in 1981, and a medical degree from the Mt. Sinai School of Medicine in 1983. He also has an M.B.A. from Columbia University, and was a Kellogg Foundation National Fellow. Dr. Gruber is currently a Senior Fellow, Healthcare Innovation and Technology Lab (HITLAB) at Columbia Presbyterian and an Advisor to QuantaEd, an innovation social network. He was recently elected Trustee to the Teaneck Board of Education.